title: Identification of a functional EGF-R/p60c-src/STAT3 pathway in colorectal carcinoma: analysis of its long-term prognostic value.
abstract: OBJECTIVE
  The Epidermal Growth Factor-Receptor (EGF-R) is frequently overexpressed in colorectal carcinoma (CRC) and patients can benefit from anti-EGF-R therapy. Yet, the relationship, within tumours, between EGF-R and the activity of downstream effectors such as the non-receptor tyrosine kinase p60c-src and the signal transducer and activator of transcription 3 (STAT3) has not been extensively analyzed.
  
  
  RESULTS
  We evaluated EGF-R, tyrosine 416-phosphorylated p60c-src (P-p60c-src), STAT3 and tyrosine 705-phosphorylated STAT3 (P-STAT3) on Tissue Micro Array (TMA) from 126 patients with CRC. Composite immunohistochemistry scores based on the intensity of labelling and the percentage of positive cells were determined on TMA for EGF-R, P-p60c-src, STAT3 and P- STAT3. A high score was found in 56%, 61%, 62% and 27% of the cases for EGF-R, P-p60c-src, STAT3 and P-STAT3 respectively. There was a significant correlation between EGF-R and P-p60c-src (p=0.006) and between P-p60c-src and P-STAT3 (p=0.0009). STAT3 was significantly correlated with vascular emboli (p=0.03) and perineural invasion (p=0.02).
  
  
  CONCLUSIONS
  The correlations between EGF-R, P-p60-src and P-STAT3 and some stage-related pathological features point to a critical role for a EGF-R-connected p60c-src-kinase-mediated pathway involving STAT3 and contributing to cell survival and proliferation within CRC tumours.
authors.affiliation: Université Paris 13, EA 3406, Bobigny, France.
authors.forename: A Tadlaoui
authors.initials: AT
authors.lastname: Hbibi
authors.forename: C
authors.initials: C
authors.lastname: Lagorce
authors.forename: P
authors.initials: P
authors.lastname: Wind
authors.forename: J P
authors.initials: JP
authors.lastname: Spano
authors.forename: G
authors.initials: G
authors.lastname: Des Guetz
authors.forename: G
authors.initials: G
authors.lastname: Milano
authors.forename: R
authors.initials: R
authors.lastname: Benamouzig
authors.forename: O
authors.initials: O
authors.lastname: Rixe
authors.forename: J-F
authors.initials: JF
authors.lastname: Morere
authors.forename: J-L
authors.initials: JL
authors.lastname: Breau
authors.forename: A
authors.initials: A
authors.lastname: Martin
authors.forename: R
authors.initials: R
authors.lastname: Fagard
mesh_terms: D000368:Aged; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D066246:ErbB Receptors / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D009367:Neoplasm Staging; D010766:Phosphorylation; D011379:Prognosis; D016392:Proto-Oncogene Proteins pp60(c-src) / Q000378:metabolism*; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D046888:Tissue Array Analysis; D014443:Tyrosine / Q000378:metabolism
chemical_list: D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D014443:Tyrosine; D066246:ErbB Receptors; D016392:Proto-Oncogene Proteins pp60(c-src)